Roundtable Discussion: Highlighting Differences in US & China Manufacturing Processes to Shift for Scalability

• Comparing US and China manufacturing mindsets to understand the impact of cost-first versus science-first development strategies
• Examining how early manufacturing decisions influence scalability, clinical feasibility, and long-term commercial success
• Examining the role of supplier ecosystems, CDMOs, and local infrastructure in enabling low-cost, high-output cell therapy manufacturing

Speakers:

Yu Cao

CEO

Stealth NewCo